Literature DB >> 2173427

Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases.

M J Gaffey1, S E Mills, E E Lack.   

Abstract

To further characterize the clinicopathologic spectrum of colorectal neuroendocrine neoplasia, 24 carcinomas with neuroendocrine differentiation were subtyped as either small cell neuroendocrine, oat cell variant (six cases), small cell neuroendocrine, intermediate variant (16 cases), or moderately differentiated neuroendocrine carcinoma (two cases). Five oat cell variants, 14 intermediate variants, and two moderately differentiated tumors were studied with antibodies to cytokeratin, vimentin, epithelial membrane antigen (EMA), neuron-specific enolase (NSE), chromogranin (CRG), synaptophysin (SYN), neurofilament, S-100 protein, carcinoembryonic antigen (CEA), and Leu-7. All tumors were immunoreactive for cytokeratin and the majority were also positive for EMA and NSE. Positivity for specific neuroendocrine markers was uncommon, with SYN reactivity noted in one oat cell variant and four intermediate variants, and CRG positivity observed in four intermediate variants and one moderately differentiated tumor. Ultrastructural analysis of four oat cell, eight intermediate, and one moderately differentiated tumor revealed neurosecretory-type, dense-core granules in all lesions, except two oat cell variants studied from paraffin-retrieved material. Hepatic and regional lymph node metastases were noted in five of six oat cell, eight of 16 intermediate, and two of two moderately differentiated tumors. Of 17 patients with follow-up (four oat cell, 11 intermediate, and two moderately differentiated tumors), only two individuals were alive after 1 year. There were no detectable differences in survival or response to treatment between morphologic subtypes. The prognosis of colorectal neuroendocrine carcinoma appears worse than for adenocarcinoma of comparable stage. Their distinction is thus warranted, especially in regard to the intermediate variant and moderately differentiated tumors, which may be potentially misinterpreted as forms of adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173427     DOI: 10.1097/00000478-199011000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  26 in total

Review 1.  Extrapulmonary small cell carcinoma.

Authors:  J A Ledermann
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

2.  The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: report of a case.

Authors:  T Okuyama; D Korenaga; S Tamura; T Yao; S Maekawa; A Watanabe; T Ikeda; K Sugimachi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Small cell carcinoma of rectum: a case report.

Authors:  Enver Ihtiyar; Cem Algin; Serap Isiksoy; Ersin Ates
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 4.  Management of primary gastric small cell carcinoma in China.

Authors:  Qin-Qin Wu; Wei-Guang Qiang; Feng Wang; Ke-Jun Dai; En-Ci Xu; Ju-Dong Luo; Qing Li; Hua Tang; Xi-Fa Zhou; Xu-Jing Lu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  A case of primary colonic small-cell carcinoma arising in a patient with long-standing ulcerative colitis.

Authors:  Renée M Marchioni Beery; Thomas J Devers; Jessica M Clement
Journal:  Gastrointest Cancer Res       Date:  2014-05

Review 6.  Pathologic research update of colorectal neuroendocrine tumors.

Authors:  Shu-Juan Ni; Wei-Qi Sheng; Xiang Du
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

Review 7.  [Neuroendocrine tumors of the gastrointestinal tract].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

8.  Rectal and anal canal neuroendocrine tumours.

Authors:  Teresa Raposo André; Margarida Brito; João Geraldes Freire; António Moreira
Journal:  J Gastrointest Oncol       Date:  2018-04

9.  High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.

Authors:  Olatunji B Alese; Renjian Jiang; Walid Shaib; Christina Wu; Mehmet Akce; Madhusmita Behera; Bassel F El-Rayes
Journal:  Oncologist       Date:  2018-11-27

10.  Gasless, video endoscopic transanal excision for carcinoid and laterally spreading tumors of the rectum.

Authors:  T Nakagoe; H Ishikawa; T Sawai; T Tsuji; M Jibiki; A Nanashima; H Yamaguchi; T Yasutake
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.